Bayer Must Include Safety Warnings of Increased Blood Clots on Yaz Labels, FDA Panel Rules
Simmons Law Firm Continues to Investigate Safety Concerns Surrounding Yaz, Yasmin Pills East St. Louis, MO (PRWEB) December 10, 2011 An independent FDA panel has voted 21-5 to require Bayer AG to update warning labels on its popular birth control Yaz to reflect new concerns regarding the drug’s safety. The overwhelming majority decision comes in light of recent studies that suggest new contraceptives containing the hormone drospirenone may be more dangerous than older drugs. The Simmons Law Firm continues to investigate these safety concerns. “Millions of women have been taking contracept
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Related Documents in PR Web
Categories
- Articles 313
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4